N-BUTYL-2-CYANOACRYLATE (HISTOACRYL) PLUS SCLEROTHERAPY VERSUS SCLEROTHERAPY ALONE IN THE TREATMENT OF BLEEDING ESOPHAGEAL-VARICES - A RANDOMIZED PROSPECTIVE-STUDY
C. Feretis et al., N-BUTYL-2-CYANOACRYLATE (HISTOACRYL) PLUS SCLEROTHERAPY VERSUS SCLEROTHERAPY ALONE IN THE TREATMENT OF BLEEDING ESOPHAGEAL-VARICES - A RANDOMIZED PROSPECTIVE-STUDY, Endoscopy, 27(5), 1995, pp. 355-357
Background and Study Aims: N-2-cyanoacrylate (Histoacryl) and endoscop
ic sclerotherapy with polidocanol have both been reported to control v
ariceal bleeding, The aim of the present study was to compare the effe
ctiveness of the combination of Histoacryl and endoscopic sclerotherap
y with polidocanol in the management of these patients regarding early
rebleeding and hospital mortality rates. Patients and Methods: One hu
ndred twenty-six consecutive patients with variceal hemorrhage treated
with injection therapy between March 1990 and July 1993 were included
in this randomized prospective study. Sixty-seven patients (Group A)
were treated with Histoacryl and conventional sclerotherapy with polid
ocanol, acid 59 patients (Group B) were treated with conventional scle
rotherapy with polidocanol alone, Histoacryl was injected intravaricea
lly during the first session in the Group A patients. Results: A signi
ficantly lower bleeding recurrence rate was found in Group A patients
who presented with active bleeding at the first treatment session (Gro
up A: 2 of 20, Group B: 8 of 18, p < 0.05), The hospital mortality was
also significantly lower in these patients (Group A: 3 of 21, Group B
: 9 of 18, p < 0.05). Conclusions: The combination of Histoacryl with
conventional sclerotherapy with polidocanol in patients with esophagea
l bleeding who present with active bleeding, at the initial injection
therapy, can improve the results of endoscopic management.